RxDoctor Payments Data

Colin Zdenek, DPM

Podiatrist · Brainerd, MNNPI 1568802908

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (43.6%), education and travel and lodging — rather than concentrated in one kind of arrangement. Stryker accounts for 65.5% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $1,646, more than ten times the $28 reported in 2019.

$3,764in general payments, 2019–2025

Across 24 payments — averaging $156.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$2K
  • Foundation Medical, LLC$1K
  • Gemini Medical LLC$32
  • Smith+Nephew$24
  • Sioux Surgical Inc$15
  • Solventum Corporation$14
  • plus $13 from 1 others

What the payments were for

  • Travel & lodging$92325%
  • Food & beverage$1,64144%
  • Education$1,20032%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker18$2,464
Foundation Medical, LLC1$1,200
Gemini Medical LLC1$32
Smith+Nephew1$24
Sioux Surgical Inc1$15
Solventum Corporation1$14
Bioventus LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,764 in reported general payments places this provider in the 80th percentile of 105 podiatrist providers in Minnesota.

See all podiatrist providers in Minnesota

Medicare billing

Part B allowed, 2024
$130,223
Medicare patients
505
Services billed
1,424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone83$438
Cephalexin38$173
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$158
Oxycodone Hcl31$46

Paid to pharmacies, not to this prescriber.

Other podiatrist in Brainerd

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →